Join us on a journey to safeguard global health. With cutting-edge technology and unwavering dedication, WuXi Vaccines is at the forefront of ensuring vaccine innovation and accessibility. Together, we're making a difference, one dose at a time. #WuXiVaccines #GlobalHealth https://wuxivaccines.com/
关于我们
WuXi Vaccines, a subsidiary of WuXi Biologics, focuses on human vaccine discovery, development and manufacture. An exciting new addition to the WuXi Biologics family, WuXi Vaccines will bring to the global vaccine industry the world-class integrated platforms and CDMO business model on which WuXi Biologics reputation is based. We provide an integrated global CDMO platform for vaccine development and manufacturing for global clients. In Dundalk, Ireland we are constructing a world class integrated vaccine manufacturing facility, which will include drug substance manufacturing (DS), drug product manufacturing (DP), Manufacturing Science and Technology Labs (MS&T) as well as Quality Control labs (QC), dedicated to manufacturing our partner’s vaccine products for the global market.
- 网站
-
https://www.wuxibiologics.com/wuxi-vaccines/
WuXi Vaccines的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Shanghai
- 类型
- 私人持股
- 创立
- 2018
- 领域
- Vaccine Development & Manufacturing
地点
-
主要
CN,Shanghai
WuXi Vaccines员工
动态
-
Thank you to everyone in WuXi Vaccines who supported our Big Pink Breakfast today for the Irish Cancer Society 💗 Shout out to Niall O'Loughlin for coming dressed for the occasion! 👏💗
-
2
-
Will you be attending the World Vaccine Congress Europe (October 28-31) in Barcelona, Spain? Xinhao Ye, PhD, Director, CMC Lead of WuXi Vaccines, will be speaking on Wednesday, October 30 at 11:10 am CET. Dr. Ye will present "Transforming Vaccine Development and Manufacturing: Integrating Technology and Accessibility for a Healthier 21st Century". Our WuXi Vaccines team will be available at booth #50 to discuss your R&D and drug discovery goals during the event. Contact us and we'll set up a convenient time to discuss your outsourcing or partnering needs. Request a meeting: https://lnkd.in/e_iR7WV9 #WorldVaccineCongressEurope #VaccineDevelopment #HealthcareInnovation #DrugDiscovery #OutsourcingNeeds #PartnershipOpportunities
-
Increasing Vaccine Efficacy with Novel Adjuvants In this thought leader article WuXi Vaccines' Xinhao Y., and Hongbing Wu describe how vaccine adjuvants can help shape immunological responses.
-
Unlock the potential of our robust WuXia™ cell line development (CLD) platform tailored for antibodies and recombinant proteins in vaccine and prophylactic antibody development. With industry-leading timelines and high-yielding production capabilities, WuXia™ CLD sets the standard for regulatory compliance and client success. Join hundreds of satisfied clients in shaping the future of vaccines: https://lnkd.in/gJbN9FGG #CellLineDevelopment #VaccineDevelopment #Biopharma #GMPProduction #CellLineEngineering #CellLineDevelopment
-
Combination products, like vaccines in pre-filled syringes or vaccine/adjuvant dual chamber, enhance vaccine delivery with improved compliance, safety, dosing accuracy, and user-friendliness. WuXi Vaccines' development and fill services offer diverse delivery systems, including needlestick injury protection features and auto-injector formats. Learn more: https://lnkd.in/eZw-7q6x #DrugProduct #VaccineDevelopment #Biopharma #Biopharmaceuticals
WuXi Vaccines Final Vaccine Drug Product Development
wuxivaccines.com
-
Explore how WuXi Vaccines' Analytical Sciences (AS) division supports our integrated vaccine development platform, collaborating with our discovery, formulation, and process development laboratories. Our extensive repertoire of analytical techniques ensures comprehensive biomolecular analysis, adjuvant analysis and protein characterization. Learn more: https://lnkd.in/e2Fey8A3 #AnalyticalDevelopment #VaccineDevelopment #CMCDevelopment #Biopharma #Bioprocessing #Biomanufacturing #mAbDevelopment
WuXi Vaccines Analytical Development
wuxivaccines.com
-
WuXi Vaccines delivers biosafety testing services integral to our integrated vaccine and prophylactic antibody development projects or as stand-alone offerings. Our ISO (CNAS) and CMA-certified laboratories in Suzhou, China, uphold rigorous standards, earning acclaim through NMPA, EMA inspections, and quality audits from over 300 global clients. Explore our biosafety services: https://lnkd.in/egd6VzCK #Biosafety #BiosafetyTesting #VaccineDevelopment #Biopharma #Bioprocessing #Biomanufacturing #QualityControl
-
WuXi Vaccines' Downstream Process Development (DSPD) facilities offer cutting-edge technologies for purification process development. We ensure GMP production standards for vaccines and prophylactic antibodies. Learn more: https://lnkd.in/er2TUkar #DownstreamProcess #GMPProduction #VaccineDevelopment #Biopharmaceuticals #VaccinesCDMO #mAbDevelopment
WuXi Vaccines Downstream Process Development
wuxivaccines.com
-
Discover WuXi Vaccines' extensive expertise in mammalian cell culture process development, supporting all stages of vaccine and prophylactic antibody development. From preclinical to late-stage optimization, from traditional fed batch to intensified, perfusion and continuous processes options, our team ensures excellence in upstream processes. Learn more: https://lnkd.in/eF_AMCQz #UpstreamDevelopment #CellCulture #Biomanufacturing #Bioprocessing #VaccineDevelopment#mAbDevelopment #VaccinesCDMO
WuXi Vaccines Upstream Process Development
wuxivaccines.com